Other OTC Pharmaceuticals - Kazakhstan

  • Kazakhstan
  • In 2024, the revenue generated in the Other OTC Pharmaceuticals market in Kazakhstan amounted to US$64.93m.
  • It is projected to experience an annual growth rate of 1.53% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, reaching US$7,171.00m in 2024.
  • In terms of per capita revenue, in Kazakhstan generates US$3.28 per person in 2024.
  • The demand for Other OTC Pharmaceuticals in Kazakhstan is driven by the increasing focus on self-medication and the availability of a wide range of products.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Kazakhstan is witnessing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Other OTC Pharmaceuticals market in Kazakhstan have shifted towards self-medication and over-the-counter products. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness among consumers about the benefits of self-care. Additionally, the rising healthcare costs and limited access to healthcare facilities in certain regions have also contributed to the growing demand for OTC pharmaceuticals in Kazakhstan. Trends in the market indicate a growing demand for vitamins and dietary supplements in Kazakhstan. This can be attributed to the increasing health consciousness among consumers and the desire to maintain a healthy lifestyle. The market is also witnessing a rise in the demand for pain relief medications, cough and cold remedies, and digestive health products. These trends are in line with the global market, where consumers are increasingly seeking preventive healthcare solutions and natural remedies for common ailments. Local special circumstances in Kazakhstan, such as the availability of a wide range of OTC pharmaceutical products and the presence of established pharmaceutical companies, have contributed to the growth of the market. The country has a well-developed healthcare infrastructure, which includes a network of pharmacies and drugstores that offer a variety of OTC products. Additionally, the government has implemented regulations to ensure the safety and quality of OTC pharmaceuticals, which has further boosted consumer confidence in these products. Underlying macroeconomic factors, such as the increasing disposable income and improving living standards in Kazakhstan, have also played a role in the growth of the Other OTC Pharmaceuticals market. As consumers have more purchasing power, they are willing to spend on healthcare products and are more likely to opt for OTC pharmaceuticals for minor ailments. Furthermore, the aging population in Kazakhstan is also contributing to the growth of the market, as older individuals are more likely to require OTC medications for chronic conditions and age-related health issues. In conclusion, the Other OTC Pharmaceuticals market in Kazakhstan is experiencing growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers in Kazakhstan increasingly value convenience, accessibility, and self-care, the demand for OTC pharmaceuticals is expected to continue to rise in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)